Share on LinkedInShare on LinkedIn

ARTICLE · 12 MAY 2010

Product Recall: Children’s Medication

On April 30, 2010, a unit of Johnson and Johnson, McNeil Consumer Healthcare in Fort Washington, Pa., commenced a voluntary recall in consultation with the U.S. Food and Drug Administration (FDA) of several children’s and infant’s over-the-counter liquid pain, fever and allergy medications.

GlobalInsurance

On April 30, 2010, a unit of Johnson and Johnson, McNeil Consumer Healthcare in Fort Washington, Pa., commenced a voluntary recall in consultation with the U.S. Food and Drug Administration (FDA) of several children's and infant's over-the-counter liquid pain, fever and allergy medications. The products include children's and infant's Zyrtec, Tylenol, Motrin and Benadryl. These medications are manufactured in the United States, and are distributed nationwide as well in Canada, the Dominican Republic, the United Arab Emirates, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago and Kuwait.

While no injures or illnesses have been reported relating to these medications, they are nonetheless being recalled based on certain quality standards. Specifically, the company believes that some of the medications may contain higher concentrations of active ingredients than the package specifies, others may contain inactive ingredients, which do not meet

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from